<i>Journal of the American Medical Association</i>｜Aspirin for metabolic dysfunction-associated steatotic liver disease without cirrhosis: A randomized clinical trial

doi:10.12449/JCH2408.gwqkjpwzjj3

Volume 40 Issue 8

Aug. 2024

Turn off MathJax

Article Contents

References

Article Navigation > Journal of Clinical Hepatology > 2024 > 40(8): 1652-1652

PDF( 903 KB)

Journal of the American Medical Association｜Aspirin for metabolic dysfunction-associated steatotic liver disease without cirrhosis: A randomized clinical trial

DOI: 10.12449/JCH2408.gwqkjpwzjj3

Published Date: 2024-08-25

Abstract

FullText(HTML)

References(0)

References

Relative Articles

[1]	Journal of Hepatology｜Protein phosphatase 6 regulates metabolic dysfunction-associated steatohepatitis via the mTORC1 pathway[J]. Journal of Clinical Hepatology, 2025, 41(2): 364-364. doi: 10.12449/JCH2502.gwqkjpwzjj2
[2]	Liver International｜MASLD, At-Risk MASH and increased liver stiffness are associated with young adulthood obesity without residual risk after losing obesity[J]. Journal of Clinical Hepatology, 2025, 41(2): 400-400. doi: 10.12449/JCH2502.gwqkjpwzjj4
[3]	Journal of Hepatology｜An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2024, 40(2): 342-342. doi: 10.12449/JCH2402.gwqkjpwzjj3
[4]	Journal of Hepatology｜Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis[J]. Journal of Clinical Hepatology, 2024, 40(9): 1777-1777. doi: 10.12449/JCH2409.gwqkjpwzjj2
[5]	Qichao GE, Lungen LU. Value of liver biopsy in the diagnosis and clinical trial of non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2024, 40(11): 2288-2292. doi: 10.12449/JCH241124
[6]	Bingqing YANG, Jingya YIN, Qi WANG. The mechanism of action of mitochondrial dysfunction in the development of non-alcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2024, 40(1): 147-150. doi: 10.12449/JCH240124
[7]	Journal of the American Heart Association｜Association of cardiopulmonary hemodynamics and mortality in veterans with liver cirrhosis: A retrospective cohort study[J]. Journal of Clinical Hepatology, 2024, 40(6): 1254-1254. doi: 10.12449/JCH2406.gwqkjpwzjj2
[8]	Journal of Hepatology｜Association of food insecurity with the prevalence and liver-related mortality of metabolic dysfunction-associated steatotic liver disease (MASLD)[J]. Journal of Clinical Hepatology, 2024, 40(10): 2126-2126. doi: 10.12449/JCH2410.gwqkjpwzjj3
[9]	Nutrition Journal｜Effects of vitamin D supplementation on liver fibrogenic factors, vitamin D receptor and liver fibrogenic microRNAs in metabolic dysfunction-associated steatotic liver disease (MASLD) patients: an exploratory randomized clinical trial[J]. Journal of Clinical Hepatology, 2024, 40(8): 1626-1626. doi: 10.12449/JCH2408.gwqkjpwzjj2
[10]	Hepatology International｜Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial[J]. Journal of Clinical Hepatology, 2023, 39(10): 2431-2431. doi: 10.3969/j.issn.1001-5256.2023.10.gwjpwzjj1
[11]	Yingshuo HUANG, Wei WEI, Xiaofei TONG, Yameng SUN, Jianxiong ZHANG, Ruihua DONG, Jidong JIA, Hong YOU. Clinical trial protocols of new drugs for nonalcoholic steatohepatitis: A systematic review[J]. Journal of Clinical Hepatology, 2022, 38(4): 798-804. doi: 10.3969/j.issn.1001-5256.2022.04.012
[12]	Ziming AN, Qin FENG. Magnetic resonance imaging-proton density fat fraction: A potential surrogate endpoint for nonalcoholic steatohepatitis clinical trials[J]. Journal of Clinical Hepatology, 2021, 37(6): 1445-1448. doi: 10.3969/j.issn.1001-5256.2021.06.047
[13]	Yingshuo HUANG, Ruihua DONG, Hong YOU. Difficulties and challenges in the clinical trial of new drugs for nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2021, 37(8): 1948-1952. doi: 10.3969/j.issn.1001-5256.2021.08.044
[14]	Huiying RAO, Lai WEI. Interpretation of clinical trial guidelines for nonalcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2021, 37(6): 1245-1248. doi: 10.3969/j.issn.1001-5256.2021.06.002
[15]	Jiahui LYU, Xiaofei LI, Lianyi GUO. Association between metabolic associated fatty liver disease and sleep disorders[J]. Journal of Clinical Hepatology, 2021, 37(12): 2854-2860. doi: 10.3969/j.issn.1001-5256.2021.12.024
[16]	Jiang LiNa, Zhao JingMin. A clinical trial on the follow-up of nonalcoholic fatty liver disease: An evaluation of pathological endpoint[J]. Journal of Clinical Hepatology, 2018, 34(12): 2505-2508. doi: 10.3969/j.issn.1001-5256.2018.12.004
[17]	Ju HuanJia, Shi JunPing. Clinical trials tracking nonalcoholic fatty liver disease: Noninvasive measures[J]. Journal of Clinical Hepatology, 2018, 34(12): 2501-2504. doi: 10.3969/j.issn.1001-5256.2018.12.003
[18]	Jia Han, Rao HuiYing. Clinical trials tracking nonalcoholic fatty liver disease: Drug classification[J]. Journal of Clinical Hepatology, 2018, 34(12): 2495-2500. doi: 10.3969/j.issn.1001-5256.2018.12.002
[19]	Mao YiMin. Clinical trials of investigational new drugs for nonalcoholic steatohepatitis:challenges in design and practice[J]. Journal of Clinical Hepatology, 2017, 33(12): 2292-2295. doi: 10.3969/j.issn.1001-5256.2017.12.007
[20]	Ji Guang. Relevant issues concerning clinical trials of traditional Chinese medicine treatment of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2014, 30(4): 299-302. doi: 10.3969/j.issn.1001-5256.2014.04.003

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (164) PDF downloads(19)

Journal of the American Medical Association｜Aspirin for metabolic dysfunction-associated steatotic liver disease without cirrhosis: A randomized clinical trial

DOI: 10.12449/JCH2408.gwqkjpwzjj3

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Journal of the American Medical Association｜Aspirin for metabolic dysfunction-associated steatotic liver disease without cirrhosis: A randomized clinical trial

DOI: 10.12449/JCH2408.gwqkjpwzjj3

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content